AMAG to acquire Perosphere for $50M

AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) will acquire Perosphere Pharmaceuticals Inc. (Danbury, Conn.) for $50 million up front. AMAG will also assume a $12 million term loan and up to $6.2 million of Perosphere's other liabilities.The deal is expected to close next quarter.

AMAG will gain global rights to ciraparantag, a small molecule anticoagulant reversal agent in Phase II testing. It has Fast Track designation from FDA. ...